Versartis, Inc. (NASDAQ:VSAR) shares fell -0.58% in last trading session and ended the day at $6.91. VSAR has a return on assets of -39.10%. Versartis, Inc. (NASDAQ:VSAR) quarterly performance is -42.18%.
Versartis, Inc. (NASDAQ:VSAR), announced that detailed two-year, safety, efficacy and adherence data from its ongoing Extension Study of somavaratan in children with GHD will be featured in two late-breaker presentations at the Endocrine Society’s 98th Annual Meeting & Expo (ENDO 2016), to be held April 1-4, 2016, in Boston, MA.
Tesaro, Inc. (NASDAQ:TSRO) ended the last trading day at $44.08. Company weekly volatility is calculated as 6.35% and price to cash ratio as 7.72. Tesaro, Inc. (NASDAQ:TSRO) showed a weekly performance of -3.61%.
TESARO, Inc. (NASDAQ:TSRO), announced that it has submitted the New Drug Application (NDA) for an intravenous (IV) formulation of rolapitant to the U.S. Food and Drug Administration (FDA). Rolapitant is a substance P/neurokinin-1 (NK-1) receptor antagonist that is marketed in tablet formulation by TESARO in the United States under the brand name VARUBI®.
On 14 March, HCA Holdings, Inc. (NYSE:HCA) shares fell -0.31% and was closed at $74.72. HCA EPS growth in last 5 year was 12.60%. HCA Holdings, Inc. (NYSE:HCA) year to date (YTD) performance is 10.48%.
On 7 March, it was reported Hospital Corporation of America (NSYE:HCA), has been recognized as a 2016 World’s Most Ethical Company® by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. This is the seventh consecutive year HCA has been honored, underscoring its consistent commitment to ethical business standards and practices.
Ultra Petroleum Corp. (NYSE:UPL) shares fell -14.42% in last trading session and ended the day at $0.69. UPL Gross Margin is 65.70% and its has a return on assets of -93.40%. Ultra Petroleum Corp. (NYSE:UPL) quarterly performance is -78.13%.
On 2 March, Ultra Petroleum Corp. (NYSE:UPL) announced that on March 1, 2016, its wholly-owned subsidiary, Ultra Resources, Inc. (“Ultra Resources”) entered into waiver and amendment agreements with all of the Ultra Resources lenders, including each of the lenders participating in Ultra Resources’ unsecured revolving credit facility and each of the investors holding unsecured senior notes issued by Ultra Resources.
La Jolla Pharmaceutical Co. (NASDAQ:LJPC) caters to the Healthcare space. Its weekly performance is 3.97%. On the last day of trading company shares ended up at $21.49.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) announced that the Company provided a corporate overview at the Cowen and Company 36th Annual Health Care Conference took place March 7–9 in Boston.